Updated: 11/30/2019

Celiac Disease

Topic
Review Topic
0
0
0%
0%
Questions
8 8
0
0
0%
0%
Evidence
5 5
0
0
https://upload.medbullets.com/topic/110039/images/dermatitisherpetiformis-knees-davinlim-e1439856524534.jpg
https://upload.medbullets.com/topic/110039/images/screen_shot_2019-11-30_at_7.29.36_pm.jpg
https://upload.medbullets.com/topic/110039/images/screen_shot_2019-11-30_at_7.34.47_pm.jpg
Snapshot
  • A 7-year-old girl is brought in by her parents for poor weight gain and recurrent diarrhea.  They have tried eliminating dairy from her diet with no improvement in symptoms.  She reports 3-5 loose stools per day for the last 6 months. The condition improves when she fasts and is usually worse when she eats fast food like pizza.  On exam, you notice several excoriated areas on the girls arms which she states are very itchy.
Introduction
  • Overview
    • chronic autoimmune disorder triggered by an environmental agent (gliadin component of gluten) in genetically predisposed individuals
      • often found in wheat and other grains such as barley and rye
    • often develops in childhood but may develop at any age
  • Epidemiology
    • demographics
      • occurs primarily in Caucasians of northern European ancestry
      • > 1:5,000 in North America  
  • Pathogenesis
    • upon exposure to gluten, an abnormal immune response leads to the production of several different autoantibodies that affects different organs
      • leads to the formation of an immune complex in the intestinal mucosa (primarily at the small intestine)
    • presence of the immune complex promotes the aggregation of killer lymphocytes, which cause mucosal damage
      • leads to the loss of villi lining (villous atrophy) and proliferation of crypt cells
    • damage of the villi lining leads to dysfunction in nutrient absorption, leading to malabsorption and anemia
  • Genetics
    • no single genetic marker exists
    • majority of patients have the variant HLA-DQ2 or HLA-DQ8 allele
      • these predisposing HLA risk alleles are necessary but not sufficient to develop celiac disease
  • Associated conditions 
    • other autoimmune diseases (e.g., diabetes mellitus type 1)
Presentation
  • Symptoms 
    • steatorrhea  
      • can lead to fat soluble vitamin deficiencies 
    • abdominal pain
    • bloating
    • flatulence
    • weight loss/failure to gain weight
    • fatigue
    • some patients are asymptomatic
    • repeated infections (if IgA deficient, common in celiac patients)
      • anaphylaxis if transfused by IgA containing blood products 
  • Physical exam
    • abdominal distension
    • pallor
    • mouth ulcers
    • short stature
    • dermatitis herpetiformis  
      • pruritic, red, papulo-vesicular lesion commonly on shoulders, elbows, and knees 
      • due to IgA deposits in the upper dermis
Imaging 
  • Dual energy X-ray absorptiometry (DEXA)
    • to identify risk of fracture and need for bone protection medication
Studies 
  • Serum labs
    • serological antibody testing 
      • best initial test
      • anti-tissue transglutaminase (tTg)-IgA antibody 
      • anti-endomysial-IgA antibody 
      • tests for IgA antibodies, will be negative in those with IgA deficiency
        • for patients with IgA deficiency, deamidated gliadin peptide (DGP) IgG testing is available
      • positive serology requires small bowel biopsy for confirmation of diagnosis
    • CBC, iron studies, folic acid, vitamin B12 to evaluate level of malnutrition/malabsorption
    • HLA testing
      • only useful in ruling out celiac disease
  • Invasive studies 
    • upper endoscopy with small bowel biopsy  
      • best confirmatory test
      • at least 4 duodenal biopsies are recommended
      • endoscopic features including loss of folds, visible fissures, nodularity, scalloping, and prominent submucosal vascularity 
      • histologic features include 
        • increased intraepithelial lymphocytes and plasma cells 
        • atrophic mucosa with loss of villi 
        • enhanced epithelial apoptosis
        • crypt hyperplasia
Differential
  • Tropical sprue
    • distinguishing factors 
      • responds to antibiotics and associated with travel to the tropics 
  • Inflammatory bowel disease 
    • distinguishing factors
      •  different histological appearance on biopsy
  • Irritable bowel syndrome 
    • distinguishing factors
      • will have negative biopsy results
Treatment
  • Lifestyle modifications
    • gluten-free diet
      • allows healing of the intestinal mucosa and resolution of all symptoms
      • eliminates the heighted risk of osteoporosis and intestinal cancer
    • dietary supplements
  • Medical treatment 
    • steroids or immunosuppressant (e.g., azathioprine)
      • consider in patients with refractory disease
    • dapsone 
      • treatment of dermatitis herpetiformis 
Complications
  • Iron deficiency anemia
  • Osteoporosis
  • Infertility
  • Neurological problems (secondary to malabsorption)
  • Intestinal lymphoma
    • develops in 10-15% of patients 
 

Please rate topic.

Average 4.8 of 13 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (8)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Volume  
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Urine  
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2
Calculator

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

You have 100% on this question.
Just skip this one for now.

(M1.GI.5) A 17-year-old male presents to his primary doctor complaining about an extremely itchy rash on his elbows and other extensor surfaces. This rash is shown in Figure A. Given the clinical associations of this rash, what other disease must be considered in this patient? Review Topic | Tested Concept

QID: 103798
FIGURES:
1

Crohn disease

7%

(5/73)

2

Ulcerative colitis

4%

(3/73)

3

Celiac disease

85%

(62/73)

4

Juvenile rheumatoid arthritis

3%

(2/73)

5

Systemic lupus erythematosis

0%

(0/73)

M1 A

Select Answer to see Preferred Response

You have 100% on this question.
Just skip this one for now.

(M1.GI.44) A 35-year-old Caucasian female presents with anemia, malaise, bloating, and diarrhea. Past genetic testing revealed that this patient carries the HLA-DQ2 allele. The physician suspects that the patient's presentation is dietary in cause. Which of the following findings would definitively confirm this diagnosis? Review Topic | Tested Concept

QID: 101101
1

CT scan showing inflammation of the small bowel wall

3%

(2/64)

2

Biopsy of the duodenum showing atrophy and blunting of villi

92%

(59/64)

3

Biopsy of the colon showing epithelial cell apoptosis

0%

(0/64)

4

Liver biopsy showing apoptosis of hepatocytes

0%

(0/64)

5

Esophageal endoscopy showing lower esophageal metaplasia

2%

(1/64)

M1 B

Select Answer to see Preferred Response

You have 100% on this question.
Just skip this one for now.

(M1.GI.77) A 30-year-old Caucasian female presents with weight loss, pallor, and periodic abdominal discomfort. Physical exam reveals pruritic, red lesions on the patient’s shoulders, elbows, and knees. An endoscopic duodenal biopsy is taken and shown in Figure A. Which of the following diseases is associated with the patient’s condition? Review Topic | Tested Concept

QID: 101134
FIGURES:
1

Zollinger-Ellison syndrome

19%

(51/264)

2

Hirschsprung’s disease

4%

(11/264)

3

Peutz-Jehger’s polyposis

17%

(45/264)

4

Hashimoto’s thyroiditis

48%

(128/264)

5

Helicobacter pylori infection

9%

(25/264)

M1 B

Select Answer to see Preferred Response

You have 100% on this question.
Just skip this one for now.

(M1.GI.26) A 22-year-old woman presents to her primary care physician complaining of a red, itchy rash on her elbows and shoulders for 2 months. She has no history of medical problems, and review of systems is positive only for occasional loose stools. She is appropriately prescribed dapsone, which relieves the rash within hours. What is the diagnosis? Review Topic | Tested Concept

QID: 104237
1

Candida intertrigo

5%

(9/192)

2

Porphyria cutanea tarda

13%

(25/192)

3

Systemic lupus erythematousus

6%

(12/192)

4

Dermatitis herpetiformis

55%

(106/192)

5

Leprosy

15%

(28/192)

M1 A

Select Answer to see Preferred Response

Evidences (6)
Topic COMMENTS (18)
Private Note